A Randomised Comparison of CPX-351 and FLAG-Ida in Adverse Karyotype AML and High-Risk MDS: The UK NCRI AML19 Trial

Jad Othman, Charlotte S Wilhelm-Benartzi, Richard Dillon, Steven Knapper, Sylvie D Freeman, Leona M Batten, Joanna Canham, Emily L Hinson, Julie Wych, Sophie Betteridge, William Villiers, Michelle Kleeman, Amanda Frances Gilkes, Nicola Potter, Ulrik Overgaard, Priyanka Mehta, KOTTARIDIS PANAGIOTIS, Jamie Cavenagh, Claire Jane Hemmaway, Claire ArnoldMike Dennis, Nigel H. Russell*

*Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    42 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'A Randomised Comparison of CPX-351 and FLAG-Ida in Adverse Karyotype AML and High-Risk MDS: The UK NCRI AML19 Trial'. Together they form a unique fingerprint.

    Medicine & Life Sciences